Topic: Pharmaceutical Lawsuit

5 chapters across the catalog

Paris Pullout
Episode 936 1:55:04 - 2:00:24

936: Paris Pullout

Ohio Opioid Lawsuit, Narcan Usage, Pharmaceutical CEO Accountability

Ohio is suing five major pharmaceutical companies for allegedly minimizing the addiction risks of prescription painkillers. The state has seen a 36% increase in overdose deaths, with the crisis now being compared to the casualty rates of the Vietnam War.

Terror Factory
Episode 709 9:30 - 10:32

709: Terror Factory

Risperdal Side Effects, Gynecomastia Litigation

Risperdal, a medication commonly prescribed for ADHD, autism, and bipolar disorder, has been linked to gynecomastia in adolescent boys. Legal advertisements are targeting families whose sons developed enlarged breasts after taking the drug, offering financial compensation from the manufacturer. The side effect has led to significant litigation against the pharmaceutical companies producing the antipsychotic medication.

Double Twister
Episode 630 49:52 - 52:14

630: Double Twister

Risperdal Lawsuits and Male Breast Development

A legal advertisement highlights the link between the antipsychotic drug Risperdal and gynecomastia, the development of breasts in men and adolescents. The hosts discuss the prevalence of such medications in schools and the cultural shift toward referring to psychiatric drugs as "meds."

Media Harmonization
Episode 482 2:17:19 - 2:19:07

482: Media Harmonization

Alcoholism Vaccine, Legal Immunity for Manufacturers

A new "vaccine" for alcoholism is in development, designed to induce an immediate hangover by blocking alcohol metabolism in the liver. The hosts speculate that labeling the drug a "vaccine" is a legal strategy to gain immunity from lawsuits under federal vaccination laws, similar to the failed smoking vaccine.

Episode 406 2:18:07 - 2:19:59

406: Zombie Walk

Anti-Nicotine Vaccine, Pharmaceutical Indemnification, Nanoparticles

A new "anti-nicotine vaccine" uses nanoparticles to trigger an immune response against the chemical. The hosts point out that labeling the product a "vaccine" provides pharmaceutical companies with legal indemnification from the U.S. government, protecting them from lawsuits related to side effects.